Annexon Biosciences (ANNX) PT Lowered to $14 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts ANNX Hot Sheet
Price: $5.29 +0.57%
Rating Summary:
11 Buy, 2 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
11 Buy, 2 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
H.C. Wainwright analyst Andrew Fein lowered the price target on Annexon Biosciences (NASDAQ: ANNX) to $14.00 (from $20.00) while maintaining a Buy rating.
You May Also Be Interested In
- Annexon Reports Second Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Annexon, Inc. (ANNX) Misses Q2 EPS by 4c
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
